These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31155425)

  • 1. Diagnostic and prognostic value of serum IL-23 in colorectal cancer.
    Elessawi DF; Alkady MM; Ibrahim IM
    Arab J Gastroenterol; 2019 Jun; 20(2):65-68. PubMed ID: 31155425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.
    Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B
    Dig Dis Sci; 2005 Jun; 50(6):1019-24. PubMed ID: 15986847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
    Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
    Wang P; Li C; Ma X; Gai X
    Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.
    Pączek S; Łukaszewicz-Zając M; Gryko M; Mroczko P; Kulczyńska-Przybik A; Mroczko B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192002
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of Serum Levels of the Adipocytokine Chemerin in Colorectal Cancer Patients.
    Alkady MM; Abdel-Messeih PL; Nosseir NM
    J Med Biochem; 2018 Jul; 37(3):313-319. PubMed ID: 30598628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Karlíková M; Čurillová M; Pecen L; Karnos V; Karnos V; Topolčan O
    Anticancer Res; 2024 Jul; 44(7):3105-3113. PubMed ID: 38925804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
    Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
    Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.
    Yüceyar S; Ertürk S; Dirican A; Cengiz A; Saner H
    Int Surg; 1996; 81(2):136-9. PubMed ID: 8912078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility and prognostic value of CA 19-9 and CEA serum markers in the long-term follow up of patients with colorectal cancer. A single-center experience over 13 years.
    Tumay V; Guner OS
    Ann Ital Chir; 2020; 91():494-503. PubMed ID: 32990277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D; Yao Y; Yang C; Zhang S
    Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
    Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
    Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
    Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
    Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.
    Pączek S; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Anticancer Res; 2021 Mar; 41(3):1421-1428. PubMed ID: 33788733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.